NASDAQ: RAPT
Rapt Therapeutics Inc Stock Ownership - Who owns Rapt Therapeutics?

Insider buying vs selling

Have Rapt Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when RAPT insiders and whales buy or sell their stock.

RAPT Shareholders

What type of owners hold Rapt Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Medicxi Ventures Management Jersey Ltd80.66%22,352,000$822.55MInsider
David V. Goeddel24.46%6,777,151$249.40MInsider
Kleiner Perkins Caufield Byers XV LLC19.83%5,494,126$202.18MInsider
Topspin Fund LP11.31%3,134,614$115.35MInsider
Medicxi Ventures Management Jersey Ltd10.08%2,794,000$102.82MInstitution
Tcg Crossover Management LLC5.90%1,636,275$60.21MInstitution
Foresite Capital Management VI LLC5.64%1,562,500$57.50MInstitution
Rtw Investments LP5.31%1,470,499$54.11MInstitution
Orbimed Advisors LLC3.92%1,086,618$39.99MInstitution
Boone Capital Management LLC2.82%782,461$28.79MInstitution

1 of 3

RAPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RAPT29.99%70.01%
MLTX58.60%24.91%Net SellingNet Selling
KURA90.23%9.77%Net SellingNet Selling
JANX63.29%36.71%Net BuyingNet Buying
VIR67.50%32.50%Net SellingNet Selling

Rapt Therapeutics Stock Ownership FAQ

Who owns Rapt Therapeutics?

Rapt Therapeutics (NASDAQ: RAPT) is owned by 59.89% institutional shareholders, 139.83% Rapt Therapeutics insiders, and 0.00% retail investors. Medicxi Ventures Management Jersey Ltd is the largest individual Rapt Therapeutics shareholder, owning 22.35M shares representing 80.66% of the company. Medicxi Ventures Management Jersey Ltd's Rapt Therapeutics shares are currently valued at $742.42M.

If you're new to stock investing, here's how to buy Rapt Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.